{"log_id": 8671850535260860182, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.000185, "average": 0.995424, "min": 0.929666}, "location": {"width": 569, "top": 216, "height": 49, "left": 190}, "words": "动物乳汁分泌实验表明拉西地平(或其代谢物)可泌入乳汁"}, {"probability": {"variance": 0.000493, "average": 0.990924, "min": 0.889077}, "location": {"width": 678, "top": 253, "height": 50, "left": 193}, "words": "妊娠和哺乳期间,需要对患者权衡利弊后再考虑用药。(参见【药理毒理】"}, {"probability": {"variance": 0.000722, "average": 0.99202, "min": 0.872755}, "location": {"width": 443, "top": 302, "height": 41, "left": 194}, "words": "应考虑本品在孕晚期引起子宫肌肉松弛的可能性"}, {"probability": {"variance": 6e-06, "average": 0.99854, "min": 0.989139}, "location": {"width": 347, "top": 349, "height": 37, "left": 162}, "words": "【儿童用药】尚无儿童使用本品的经验"}, {"probability": {"variance": 2.1e-05, "average": 0.996696, "min": 0.985971}, "location": {"width": 325, "top": 389, "height": 41, "left": 161}, "words": "【老年患者用药】参见【用法用量】"}, {"probability": {"variance": 2e-06, "average": 0.998691, "min": 0.994967}, "location": {"width": 155, "top": 441, "height": 28, "left": 161}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.000903, "average": 0.992537, "min": 0.80852}, "location": {"width": 879, "top": 462, "height": 50, "left": 196}, "words": "本品与其他有降压作用的药物,包括抗高血压药物如利尿剂、β阻滞剂或血管紧张素转化酶抑制"}, {"probability": {"variance": 5e-06, "average": 0.998414, "min": 0.992006}, "location": {"width": 338, "top": 518, "height": 38, "left": 155}, "words": "剂合用,可能产生附加的降压的作用"}, {"probability": {"variance": 3e-06, "average": 0.998692, "min": 0.994269}, "location": {"width": 355, "top": 560, "height": 36, "left": 200}, "words": "与西咪替丁合用可增加本品的血药浓度"}, {"probability": {"variance": 0.021919, "average": 0.872575, "min": 0.664713}, "location": {"width": 115, "top": 532, "height": 53, "left": 955}, "words": "医药为"}, {"probability": {"variance": 0.007776, "average": 0.963133, "min": 0.631159}, "location": {"width": 516, "top": 594, "height": 49, "left": 196}, "words": "拉西地平与白蛋白和海1糖蛋白高度结合(结合率>95%"}, {"probability": {"variance": 0.001855, "average": 0.989773, "min": 0.748964}, "location": {"width": 693, "top": 635, "height": 47, "left": 197}, "words": "拉西地平与常用抗高血压药物如民阻滞剂、利尿剂合用,或与地高辛、甲苯"}, {"probability": {"variance": 0.003755, "average": 0.93648, "min": 0.875201}, "location": {"width": 159, "top": 616, "height": 72, "left": 950}, "words": "合用"}, {"probability": {"variance": 0.001926, "average": 0.976966, "min": 0.868025}, "location": {"width": 167, "top": 694, "height": 27, "left": 157}, "words": "时,无特殊相互作"}, {"probability": {"variance": 0.001391, "average": 0.980903, "min": 0.870966}, "location": {"width": 711, "top": 718, "height": 47, "left": 200}, "words": "与其它二氢吡啶相似,拉两地平不能与葡萄柚汁同服,因其生物利用度会改变"}, {"probability": {"variance": 0.00479, "average": 0.976506, "min": 0.635585}, "location": {"width": 878, "top": 751, "height": 60, "left": 199}, "words": "对于服用环孢素的肾移植患者临床试验表明,拉西地平可以逆转由环孢素因其引起的肾血流量"}, {"probability": {"variance": 2e-06, "average": 0.999185, "min": 0.995188}, "location": {"width": 212, "top": 813, "height": 34, "left": 158}, "words": "及肾小球滤过率的减少"}, {"probability": {"variance": 2.4e-05, "average": 0.997157, "min": 0.971812}, "location": {"width": 875, "top": 838, "height": 48, "left": 202}, "words": "已知拉西地平可通过细胞色素CYP3A4代谢,因此,合用CYP3A4抑制剂和诱导剂可能会影响拉"}, {"probability": {"variance": 8e-06, "average": 0.997515, "min": 0.990905}, "location": {"width": 187, "top": 896, "height": 32, "left": 162}, "words": "西地平的代谢和清除"}, {"probability": {"variance": 8e-06, "average": 0.997741, "min": 0.989556}, "location": {"width": 345, "top": 931, "height": 38, "left": 172}, "words": "【药物过量】尚无服用本品过量的病例"}, {"probability": {"variance": 9e-06, "average": 0.998531, "min": 0.98224}, "location": {"width": 876, "top": 961, "height": 47, "left": 202}, "words": "服用本品过量最可能发生的问题是外周血管舒张过度所致低血压和心动过速。理论上,可能发生"}, {"probability": {"variance": 1e-06, "average": 0.999246, "min": 0.997738}, "location": {"width": 277, "top": 1015, "height": 36, "left": 162}, "words": "心动过缓或房室传导时间延长"}, {"probability": {"variance": 4.8e-05, "average": 0.997593, "min": 0.967449}, "location": {"width": 689, "top": 1046, "height": 44, "left": 205}, "words": "无特殊解毒方法,通用标准措施为监测心功能,给予适当的支持和治疗措施"}, {"probability": {"variance": 1e-06, "average": 0.999183, "min": 0.996522}, "location": {"width": 114, "top": 1104, "height": 27, "left": 169}, "words": "【药理毒理】"}, {"probability": {"variance": 4e-05, "average": 0.997422, "min": 0.960628}, "location": {"width": 878, "top": 1123, "height": 53, "left": 202}, "words": "1药理:本品为特异性高效钙离子拮抗剂,对于血管平滑肌的钙通道具有高度选择性。其主要作"}, {"probability": {"variance": 4.5e-05, "average": 0.997654, "min": 0.956409}, "location": {"width": 917, "top": 1169, "height": 48, "left": 164}, "words": "用为扩张外周小动脉,减少外周血管阻力和降低血压。健康志愿者口服4mg的拉西地平后,可观察到"}, {"probability": {"variance": 0.002262, "average": 0.987391, "min": 0.731138}, "location": {"width": 913, "top": 1209, "height": 50, "left": 168}, "words": "QTc间期的轻度延长。欧洲一项为期四年的随机、双盲ELSA临床研究(欧洲拉西地平用于动脉粥样硬"}, {"probability": {"variance": 0.005783, "average": 0.984003, "min": 0.522188}, "location": {"width": 825, "top": 1253, "height": 49, "left": 164}, "words": "化临床研究)显示,服用拉西地平的患者超声检查颈动脉内膜中膜厚度(IMT)有明显改善"}, {"probability": {"variance": 0.005771, "average": 0.967254, "min": 0.755083}, "location": {"width": 164, "top": 1313, "height": 28, "left": 205}, "words": "2.毒理:通过对S"}, {"probability": {"variance": 3.9e-05, "average": 0.997492, "min": 0.970301}, "location": {"width": 644, "top": 1294, "height": 44, "left": 439}, "words": " Dawley鼠及 Beagle狗78周的急性、亚急性、慢性毒理研究显示,最大"}, {"probability": {"variance": 0.009308, "average": 0.972176, "min": 0.472048}, "location": {"width": 920, "top": 1337, "height": 50, "left": 164}, "words": "重复剂量:鼠为32mg/kg(1个月)或20mgkg(6个月)。狗为8.5mg/kg(1个月)或5mg/kg(6个"}, {"probability": {"variance": 7e-06, "average": 0.998414, "min": 0.985199}, "location": {"width": 883, "top": 1379, "height": 50, "left": 168}, "words": "月)。与本品药效性相关的变化包括心肌收缩力降低和齿龈增生,及大鼠便秘。以上作用是可逆的"}, {"probability": {"variance": 1.1e-05, "average": 0.998045, "min": 0.985556}, "location": {"width": 856, "top": 1421, "height": 49, "left": 207}, "words": "妊娠大鼠或家兔中给予拉西地平后没有发现发育毒性迹象。大鼠中进行的生育和生殖研究显示"}, {"probability": {"variance": 0.000432, "average": 0.995966, "min": 0.85983}, "location": {"width": 917, "top": 1463, "height": 48, "left": 168}, "words": "在母体毒性剂量下可见胚胎毒性,并且与预期的钙通道拮抗剂对子宫肌层的药理学活性一致,在高剂"}, {"probability": {"variance": 0.000162, "average": 0.996185, "min": 0.916537}, "location": {"width": 895, "top": 1505, "height": 47, "left": 168}, "words": "量下可见妊娠期延长和分娩困难。药理学已知钙通道拮抗剂有干扰分娩时子宫肌层正常功能的作用"}], "language": 3}